"However, in order to move toward our goal of launching clinical trials for these patients, an understanding of the natural history of these disorders is critical for developing outcome measures ...

Global CRO Worldwide Clinical Trials has enlisted AI tech firm NetraMark to discover patient subpopulations hidden inside complex data sets. Under the partnership, Worldwide will use NetraMark’s ...

The meeting with the FDA regarding the design of our program may lead to the start of a trial in 2026. Early intervention may be particularly beneficial in pediatric patients, given the ...

Under this agreement, NetraMark's AI technology will initially be used for Phase 2 (neuroscience and oncology clinical trials) and select Phase 3 clinical trials conducted by Worldwide ...

Patients with moderate to severe active systemic lupus erythematosus (SLE) who began treatment with anifrolumab in the TULIP-1 and TULIP-2 trials experienced a statistically significant reduction ...

USA jThe Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, The Eisenburg R&D Authority, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel kDivision ...

These findings overall have raised expectations for the phase 3 POETYK SLE trials that are underway. These trials (POETYK SLE 1 and POETYK SLE 2) are now recruiting patients and have the potential ...